KOSPI · Healthcare · ₩886B
₩61,400-0.81%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 18.7% · as of 26.10.26
Among 97 제약 peers
Quarterly Revenue Growth
“이번 분기, 매출 성장은 이어졌고 이제 이익 회복을 볼 때예요.”
In the company's words · 2026 2분기 filing